Ponalrestat (Standard) (ICI 128436 (Standard)) is the analytical standard of Ponalrestat ( HY-106697 ). This product is intended for research and analytical applications. Ponalrestat (ICI 128436) is an orally active, selective and noncompetitive aldose reductase (AKR1B1; ALR) inhibitor. Ponalrestat selectively inhibits ALR2 (K i =7.7 nM) over ALR1 (K i =60 μM). Ponalrestat inhibits the conversion of glucose to sorbitol.
Products | Products > Signaling Pathways > Others | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Metabolic Disease | Products > Signaling Pathways > Reference Standards | Products > Signaling Pathways > Aldose Reductase
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.